Your browser doesn't support javascript.
loading
Long disease-free survival (48 months) in a breast cancer patient with ovarian and pelvic metastasis-a case report.
Feng, Yu; Zhao, Xia; Lv, Shuzhen; Xiong, Bingjun; Li, Yanping; Zhang, Man.
Afiliação
  • Feng Y; Department of Breast Surgery, Beijing Shijitan Hospital, Capital Medical University, Beijing, China.
  • Zhao X; Department of Clinical Laboratory, Beijing Shijitan Hospital, Capital Medical University, Beijing Key Laboratory of Urinary Cellular and Molecular Diagnostics, Beijing, China.
  • Lv S; Department of Breast Surgery, Beijing Shijitan Hospital, Capital Medical University, Beijing, China.
  • Xiong B; Department of Breast Surgery, Beijing Shijitan Hospital, Capital Medical University, Beijing, China.
  • Li Y; Department of Breast Surgery, Beijing Shijitan Hospital, Capital Medical University, Beijing, China.
  • Zhang M; Department of Breast Surgery, Beijing Shijitan Hospital, Capital Medical University, Beijing, China.
Transl Cancer Res ; 9(12): 7669-7675, 2020 Dec.
Article em En | MEDLINE | ID: mdl-35117367
Breast cancer is one of the most common malignant tumors in woman. Ovarian and pelvic metastasis in breast cancer are very rare, and the prognosis is often poor. Lacking typical clinical manifestation, misdiagnose is common. We report a case about a middle-aged postmenopausal woman with complaints of finding a left breast mass and irregular vaginal bleeding. Through ultrasound-guided core-needle biopsy of the masses, the patient's final diagnosis was breast cancer with ovarian and pelvic metastasis. The patient received combinations of chemotherapy (intravenous infusion or peritoneal perfusion), radical surgery (gynecological operation and modified radical mastectomy), radiation and endocrine therapy. Forty-eight months follow-up showed that the patient is generally in good condition and had no signs of local recurrence or metastasis. Invasive ductal carcinoma (IDC) of the breast with unilateral ovarian and pelvic metastasis is rare. It is not easy to differentiate from primary ovarian malignant tumor, and the prognosis is generally poor. We chose a combination chemotherapy regimen sensitive to both breast and ovarian tumors for the patient. The therapeutic effect is remarkable. Only a small number of tumor cells were found in pelvic and ovarian tumors. The patient's breast tumors reached pathological complete remission (pCR), which might be the reason for the patient's good prognosis.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Transl Cancer Res Ano de publicação: 2020 Tipo de documento: Article País de afiliação: China

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Transl Cancer Res Ano de publicação: 2020 Tipo de documento: Article País de afiliação: China